side effects include:
headache
dizziness
somnolence
diarrhea
month of therapy
gynecomastia

im therapy
transient pain at injection site
nervous system
side effects
headache
dizziness
somnolence
severe mental status changes
including depression
agitation
disorientation
confusion
delirium
unsteadiness
speech
lethargy
hallucinations
coma
literature
other nervous system effects
extrapyramidal symptoms
cerebellar syndrome with encephalopathy
paresthesias
critical illness
age
liver disease
increased risk for central nervous system toxicity
mechanism by which cimetidine
mental status changes
increased serum concentrations of cimetidine
cimetidine sulfoxide
advanced age
many case reports of mental status changes
pharmacokinetics of cimetidine
renal function
making
making renal dysfunction
advanced age
likely risk factor than age
addition
cimetidine penetration of the blood brain barrier
patients with liver disease
onset of symptoms
days of start of therapy
following discontinuation of cimetidine
mental status
several days
psychiatric side effects
other signs
symptoms of neurologic toxicity
unsteadiness
speech
lethargy
age
renal dysfunction
liver disease
predisposing factors in these cases
psychiatric side effects in the form of severe depression
suicidal ideation
paranoia
frank psychosis
healthy patients
psychiatric side effects
depression
paranoia
agitation
mania
hallucinations
psychosis
loss of libido
side effects
other signs
symptoms of neurologic toxicity
critical illness
age
liver disease
increased risk for central nervous system toxicity
including
psychiatric disturbances
endocrine side effects
gynecomastia
occurring
patients
nonhypersecretory conditions for month
patients
pathologic hypersecretory conditions
cases
majority of cases
hormone levels
normal range
addition
galactorrhea
impotence
transient alopecia
case of possible cimetidine-induced hypoparathyroidism
large population-based cohort study
men
risk of gynecomastia
cimetidine
ranitidine
misoprostol
omeprazole
men
cimetidine
gynecomastia
men
cimetidine
relative risk of gynecomastia during cimetidine treatment
control population
cimetidine
use of daily doses of mg
relative risk
luteinizing hormone
lh
follicle-stimulating hormone
fsh
serum prolactin
testosterone
estradiol levels
normal range in patients
gynecomastia
breast tenderness
cimetidine
serum testosterone
lh
estradiol
increases in serum prolactin
occasion
severe hypocalcemia
elderly woman
cimetidine
evidence in this case
possible cimetidine-induced reduction in parathyroid hormone with subsequent hypocalcemia
study
study
involving medical icu patients
requiring invasive blood pressure monitoring for circulatory instability
need
repeated arterial blood gas
average decrease of mmhg in systolic
mmhg in diastolic pressure
patients
following administration of cimetidine
active ingredient
tagamet
mg
minutes
patients
systolic pressure
mmhg
most cardiovascular side effects
noted following
noted following rapid intravenous administration
administration by slow infusion
incidence of such effects
serious cardiovascular events
including sinus arrest
continuous intravenous infusions
oral administration
cardiovascular
side effects
rapid intravenous administration
tachycardia
bradycardia
hypotension
qt interval prolongation
premature ventricular contractions
junctional rhythm
av block
sinus arrest
h receptor antagonist
hematologic side effects
leukopenia
eosinophilia
neutropenia
thrombocytopenia
agranulocytosis
aplastic anemia
manufacturer
rare cases of autoimmune hemolytic anemia
rare cases of irreversible
fatal blood dyscrasias
literature
hematologic abnormalities
patients
cimetidine
fever
chills
sore throat
other signs
symptoms
blood dyscrasia
hepatic side effects
elevations in liver function tests
hepatitis
mixed cholestatic-hepatocellular types
presentations of cimetidine-induced hepatitis
features
hypersensitivity response
serious hepatotoxicity
cimetidine
bridging
bridging hepatic necrosis
centrilobular hepatic necrosis
intrahepatic cholestasis
biopsy in cases of cimetidine-induced hepatitis
cases
liver toxicity
fever
rash
eosinophilia
suggesting
hypersensitivity etiology
cimetidine-induced hepatitis in a patient with a history of famotidine-induced hepatitis
case
extreme caution
initiating cimetidine therapy in a patient with a history of other h-antagonist-induced hepatotoxicity
liver injury
fatal outcome
use of other h receptor antagonists
renal side effects
elevations in serum creatinine
such elevations
competitive inhibition of tubular secretion of creatinine
result of impaired glomerular filtration
renal toxicity
rare cases of acute renal failure
interstitial nephritis
elevations in serum creatinine
cimetidine therapy
cimetidine
secretion of creatinine by the renal proximal tubules
reduction in creatinine clearance
creatinine
cimetidine transport
high concentrations
overt renal toxicity
renal failure
interstitial nephritis
cases
cimetidine-induced renal toxicity
delayed-type hypersensitivity
gastrointestinal side effects
diarrhea
severe cases
nausea/vomiting
constipation
dry mouth
taste changes
addition
cases of parotitis
phytobezoars
pancreatitis
dermatologic side effects
mild rash
severe dry skin
xerosis
seborrheic dermatitis
erythema
annular centrifugum
erythema multiforme
stevens-johnson syndrome
exfoliative dermatitis
toxic epidermal necrolysis
reversible alopecia
sebum-inhibitory effects
proposed mechanisms by which cimetidine
severe xerosis
asteatotic dermatitis
musculoskeletal side effects
arthralgias
inflammatory arthritis
gout-like arthritis
myalgias
manufacturer
rare cases of polymyositis although causality
immunologic side effects
case of exacerbation of cutaneous systemic lupus erythematosus
cimetidine-induced cutaneous vasculitis
hyperinfection
immunocompromised patients
hypersensitivity side effects
urticaria
pruritus
fever
angioedema
anaphylaxis
addition
case of drug fever in association with leukocytosis
abdominal pain
vasculitis
discontinuation of the drug
side effects of tagamet
fda
healthcare professional for medical advice